Gan & Lee Pharmaceuticals announced that the company plans to repurchase shares using its own funds through centralized bidding trading, with a repurchase amount not less than 0.15 billion and not exceeding 0.3 billion. The repurchase price will not exceed 62.76 yuan per share, and the repurchased shares will be used for employee shareholding plans or stock-based incentives. The repurchase period will not exceed 12 months from the date of approval by the board of directors.
甘李药业：拟以1.5亿元至3亿元自有资金回购股份
Gan & Lee Pharmaceuticals plans to repurchase shares using its own funds in the range of 0.15 billion yuan to 0.3 billion yuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated